These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 30376860)

  • 1. Assessment of parasite clearance following treatment of severe malaria with intravenous artesunate in Ugandan children enrolled in a randomized controlled clinical trial.
    Byakika-Kibwika P; Nyakato P; Lamorde M; Kiragga AN
    Malar J; 2018 Oct; 17(1):400. PubMed ID: 30376860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piperaquine concentration and malaria treatment outcomes in Ugandan children treated for severe malaria with intravenous Artesunate or quinine plus Dihydroartemisinin-Piperaquine.
    Byakika-Kibwika P; Ssenyonga R; Lamorde M; Blessborn D; Tarning J
    BMC Infect Dis; 2019 Dec; 19(1):1025. PubMed ID: 31795967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous artesunate plus Artemisnin based Combination Therapy (ACT) or intravenous quinine plus ACT for treatment of severe malaria in Ugandan children: a randomized controlled clinical trial.
    Byakika-Kibwika P; Achan J; Lamorde M; Karera-Gonahasa C; Kiragga AN; Mayanja-Kizza H; Kiwanuka N; Nsobya S; Talisuna AO; Merry C
    BMC Infect Dis; 2017 Dec; 17(1):794. PubMed ID: 29281988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmodium falciparum clearance time in Malawian children with cerebral malaria: a retrospective cohort study.
    Saidi AM; Guenther G; Izem R; Chen X; Seydel K; Postels D
    Malar J; 2021 Oct; 20(1):408. PubMed ID: 34663346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar.
    Kyaw MP; Nyunt MH; Chit K; Aye MM; Aye KH; Aye MM; Lindegardh N; Tarning J; Imwong M; Jacob CG; Rasmussen C; Perin J; Ringwald P; Nyunt MM
    PLoS One; 2013; 8(3):e57689. PubMed ID: 23520478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Detection of Residual Parasitemia after Pyronaridine-Artesunate or Artemether-Lumefantrine Treatment of Uncomplicated
    Roth JM; Sawa P; Omweri G; Makio N; Osoti V; de Jong MD; Schallig HDFH; Mens PF
    Am J Trop Med Hyg; 2018 Oct; 99(4):970-977. PubMed ID: 30105967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial.
    von Seidlein L; Milligan P; Pinder M; Bojang K; Anyalebechi C; Gosling R; Coleman R; Ude JI; Sadiq A; Duraisingh M; Warhurst D; Alloueche A; Targett G; McAdam K; Greenwood B; Walraven G; Olliaro P; Doherty T
    Lancet; 2000 Jan; 355(9201):352-7. PubMed ID: 10665554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No evidence of delayed parasite clearance after oral artesunate treatment of uncomplicated falciparum malaria in Mali.
    Maiga AW; Fofana B; Sagara I; Dembele D; Dara A; Traore OB; Toure S; Sanogo K; Dama S; Sidibe B; Kone A; Thera MA; Plowe CV; Doumbo OK; Djimde AA
    Am J Trop Med Hyg; 2012 Jul; 87(1):23-8. PubMed ID: 22764287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmodium falciparum clearance in clinical studies of artesunate-amodiaquine and comparator treatments in sub-Saharan Africa, 1999-2009.
    Zwang J; Dorsey G; Mårtensson A; d'Alessandro U; Ndiaye JL; Karema C; Djimde A; Brasseur P; Sirima SB; Olliaro P
    Malar J; 2014 Mar; 13():114. PubMed ID: 24666562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining the in vivo phenotype of artemisinin-resistant falciparum malaria: a modelling approach.
    White LJ; Flegg JA; Phyo AP; Wiladpai-ngern JH; Bethell D; Plowe C; Anderson T; Nkhoma S; Nair S; Tripura R; Stepniewska K; Pan-Ngum W; Silamut K; Cooper BS; Lubell Y; Ashley EA; Nguon C; Nosten F; White NJ; Dondorp AM
    PLoS Med; 2015 Apr; 12(4):e1001823. PubMed ID: 25919029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and parasite clearance of artemisinin-resistant Plasmodium falciparum infection: A pilot and a randomised volunteer infection study in Australia.
    Watts RE; Odedra A; Marquart L; Webb L; Abd-Rahman AN; Cascales L; Chalon S; Rebelo M; Pava Z; Collins KA; Pasay C; Chen N; Peatey CL; Möhrle JJ; McCarthy JS
    PLoS Med; 2020 Aug; 17(8):e1003203. PubMed ID: 32822347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial of the efficacy of artesunate and three quinine regimens in the treatment of severe malaria in children at the Ebolowa Regional Hospital, Cameroon.
    Maka DE; Chiabi A; Ndikum V; Achu D; Mah E; Nguefack S; Nana P; Njoumemi Z; Mbacham W; Mbonda E
    Malar J; 2015 Oct; 14():429. PubMed ID: 26520401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
    Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Tambo E; Fateye BA; Happi TC; Oduola AM
    Trop Med Int Health; 2005 Nov; 10(11):1161-70. PubMed ID: 16262741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial.
    Gaur AH; McCarthy JS; Panetta JC; Dallas RH; Woodford J; Tang L; Smith AM; Stewart TB; Branum KC; Freeman BB; Patel ND; John E; Chalon S; Ost S; Heine RN; Richardson JL; Christensen R; Flynn PM; Van Gessel Y; Mitasev B; Möhrle JJ; Gusovsky F; Bebrevska L; Guy RK
    Lancet Infect Dis; 2020 Aug; 20(8):964-975. PubMed ID: 32275867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial.
    Dorsey G; Staedke S; Clark TD; Njama-Meya D; Nzarubara B; Maiteki-Sebuguzi C; Dokomajilar C; Kamya MR; Rosenthal PJ
    JAMA; 2007 May; 297(20):2210-9. PubMed ID: 17519410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UK malaria treatment guidelines.
    Lalloo DG; Shingadia D; Pasvol G; Chiodini PL; Whitty CJ; Beeching NJ; Hill DR; Warrell DA; Bannister BA;
    J Infect; 2007 Feb; 54(2):111-21. PubMed ID: 17215045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: an individual patient data meta-analysis.
    ; Abdulla S; Ashley EA; Bassat Q; Bethell D; Björkman A; Borrmann S; D'Alessandro U; Dahal P; Day NP; Diakite M; Djimde AA; Dondorp AM; Duong S; Edstein MD; Fairhurst RM; Faiz MA; Falade C; Flegg JA; Fogg C; Gonzalez R; Greenwood B; Guérin PJ; Guthmann JP; Hamed K; Hien TT; Htut Y; Juma E; Lim P; Mårtensson A; Mayxay M; Mokuolu OA; Moreira C; Newton P; Noedl H; Nosten F; Ogutu BR; Onyamboko MA; Owusu-Agyei S; Phyo AP; Premji Z; Price RN; Pukrittayakamee S; Ramharter M; Sagara I; Se Y; Suon S; Stepniewska K; Ward SA; White NJ; Winstanley PA
    Malar J; 2015 Sep; 14():359. PubMed ID: 26390866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early rising asexual parasitaemia in Nigerian children following a first dose of artemisinin-based combination treatments of falciparum malaria.
    Sowunmi A; Akano K; Ayede AI; Adewoye EO; Ntadom G; Fatunmbi B; Gbotosho GO; Folarin OA; Happi CT
    BMC Infect Dis; 2017 Jan; 17(1):110. PubMed ID: 28143417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmodium falciparum clearance is rapid and pitting independent in immune Malian children treated with artesunate for malaria.
    Ndour PA; Lopera-Mesa TM; Diakité SA; Chiang S; Mouri O; Roussel C; Jauréguiberry S; Biligui S; Kendjo E; Claessens A; Ciceron L; Mazier D; Thellier M; Diakité M; Fairhurst RM; Buffet PA
    J Infect Dis; 2015 Jan; 211(2):290-7. PubMed ID: 25183768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different Plasmodium falciparum clearance times in two Malian villages following artesunate monotherapy.
    Kone A; Sissoko S; Fofana B; Sangare CO; Dembele D; Haidara AS; Diallo N; Coulibaly A; Traore A; Toure S; Haidara K; Sanogo K; Sagara I; Beshir KB; Gil JP; Doumbo OK; Djimde AA
    Int J Infect Dis; 2020 Jun; 95():399-405. PubMed ID: 32320811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.